-
1
-
-
0842305253
-
Incidence de la mortalité du cancer de la prostate en France/Tendances évolutives entre 1978 et 2000
-
Bauvin E, Remontet L, Grosclaude P, réseau FRANCIM, Cepidc. Incidence de la mortalité du cancer de la prostate en France/Tendances évolutives entre 1978 et 2000. Prog Urol 2003;13:1334-9.
-
(2003)
Prog Urol
, vol.13
, pp. 1334-1339
-
-
Bauvin, E.1
Remontet, L.2
Grosclaude, P.3
-
2
-
-
1942539318
-
Screening decreases prostate cancer mortality: 11-years follow up of the 1988 Quebec prospective randomised controlled trial
-
Labrie F, Candas B, Cusan L et al. Screening decreases prostate cancer mortality: 11-years follow up of the 1988 Quebec prospective randomised controlled trial. Prostate 2004;59:311-8.
-
(2004)
Prostate
, vol.59
, pp. 311-318
-
-
Labrie, F.1
Candas, B.2
Cusan, L.3
-
3
-
-
0034285719
-
Prostate cancer: To screen or not to screen?
-
Neal DE, Donovan JL. Prostate cancer: to screen or not to screen? Lancet Oncol 2000;1:17-24.
-
(2000)
Lancet Oncol
, vol.1
, pp. 17-24
-
-
Neal, D.E.1
Donovan, J.L.2
-
4
-
-
0037014792
-
Overdiagnosis due to prostate specific antigen screening: Lessons from US prostate cancer incidence trends
-
Etzioni R, Penson DF, Legler JM et al. Overdiagnosis due to prostate specific antigen screening: lessons from US prostate cancer incidence trends. J Natl cancer Inst 2002;94:981-90.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 981-990
-
-
Etzioni, R.1
Penson, D.F.2
Legler, J.M.3
-
5
-
-
0038275923
-
Lead times and overdetection due to prostate antigen screening: Estimates from the European Randomized study of screening for prostate cancer
-
Draisma G, Boer R, Otto SJ, Van Der Cruijsen IW, Damhuis RA, Schroder FH, De Koning HJ. Lead times and overdetection due to prostate antigen screening: estimates from the European Randomized study of screening for prostate cancer. J Natl cancer Inst 2003;95:868-78.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 868-878
-
-
Draisma, G.1
Boer, R.2
Otto, S.J.3
Van Der Cruijsen, I.W.4
Damhuis, R.A.5
Schroder, F.H.6
De Koning, H.J.7
-
6
-
-
4544254807
-
The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
-
Stamey TA, Cadwell M, Mcneal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004;172:1297-301.
-
(2004)
J Urol
, vol.172
, pp. 1297-1301
-
-
Stamey, T.A.1
Cadwell, M.2
Mcneal, J.E.3
Nolley, R.4
Hemenez, M.5
Downs, J.6
-
7
-
-
0035047917
-
Extended sector biopsy for detection of carcinoma of the prostate
-
Niemann TR, Bahnson RR. Extended sector biopsy for detection of carcinoma of the prostate. Urol Oncol 2001;6:91-3.
-
(2001)
Urol Oncol
, vol.6
, pp. 91-93
-
-
Niemann, T.R.1
Bahnson, R.R.2
-
8
-
-
0036668361
-
Repeat prostate biopsy: Who, how and when? A review
-
Djavan B, Remzi M, Schulmann C, Marberger M, Zlotta A. Repeat prostate biopsy: who, how and when? A review. Eur Urol 2002;42:93.
-
(2002)
Eur Urol
, vol.42
, pp. 93
-
-
Djavan, B.1
Remzi, M.2
Schulmann, C.3
Marberger, M.4
Zlotta, A.5
-
9
-
-
18244383076
-
Prostate biopsy: Who, how and when? An Update
-
Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when? An Update. Can J Urol 2005;12:44-8.
-
(2005)
Can J Urol
, vol.12
, pp. 44-48
-
-
Djavan, B.1
Milani, S.2
Remzi, M.3
-
10
-
-
26444476398
-
Comment nous faisons une biopsie de prostate
-
Cornud F, Peyromaure M, Veillefond A, Zerbib M, Flam T, Chevrot A. Comment nous faisons une biopsie de prostate. Feuillets de radiologie 2005;45:297-307.
-
(2005)
Feuillets de Radiologie
, vol.45
, pp. 297-307
-
-
Cornud, F.1
Peyromaure, M.2
Veillefond, A.3
Zerbib, M.4
Flam, T.5
Chevrot, A.6
-
11
-
-
0023233060
-
Prostate specific antigen as a serum marker for adenocarcinoma of the prostate
-
Stamey TA, Yang N, Hay AR, Mc Neal JE. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl J Med 1987;317:909-16.
-
(1987)
New Engl J Med
, vol.317
, pp. 909-916
-
-
Stamey, T.A.1
Yang, N.2
Hay, A.R.3
Mc Neal, J.E.4
-
12
-
-
0034287457
-
Pretreatment nomogramm for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
-
Kattan MW, Zelefsky MJ, Kupelian PA. Pretreatment nomogramm for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J clin Oncol 2000;18:3352-9.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3352-3359
-
-
Kattan, M.W.1
Zelefsky, M.J.2
Kupelian, P.A.3
-
13
-
-
0018194518
-
Ultrasonic evaluation oi the prostatic nodule
-
Resnick NI, Willard JW, Boyce WH. Ultrasonic evaluation oi the prostatic nodule. J Urol 1981;120:86-9.
-
(1981)
J Urol
, vol.120
, pp. 86-89
-
-
Resnick, N.I.1
Willard, J.W.2
Boyce, W.H.3
-
14
-
-
0027391671
-
Prostate: Techniques, results and potential applications of color Doppler US scanning
-
Rifkin M, Sudakoff G, Alexander A. Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 1993;186:509-13.
-
(1993)
Radiology
, vol.186
, pp. 509-513
-
-
Rifkin, M.1
Sudakoff, G.2
Alexander, A.3
-
15
-
-
0027382407
-
Prostate cancer and the role of color Doppler US
-
Kelly I, Lees W, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993;189:153-6.
-
(1993)
Radiology
, vol.189
, pp. 153-156
-
-
Kelly, I.1
Lees, W.2
Rickards, D.3
-
16
-
-
0030999912
-
The role of color Doppler and staging biopsies in prostate cancer detection
-
Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997;49:31-4.
-
(1997)
Urology
, vol.49
, pp. 31-34
-
-
Bree, R.L.1
-
17
-
-
0031449903
-
Color Doppler Imaging in predicting the biologic behavior of prostate cancer: Correlation with disease-free survival
-
Ismail M, Petersen Ro, Alexander AA, Newschaffer C, Gomella Lg. Color Doppler Imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 1997;50:906-12.
-
(1997)
Urology
, vol.50
, pp. 906-912
-
-
Ismail, M.1
Petersen, Ro.2
Alexander, A.A.3
Newschaffer, C.4
Gomella, Lg.5
-
18
-
-
0031802819
-
Prostatic cancer: Role of color Doppler imaging in transrectal sonography
-
Lavoipierre AM, Snow RM, Frydenberg M et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 1998;171:205-10.
-
(1998)
AJR Am J Roentgenol
, vol.171
, pp. 205-210
-
-
Lavoipierre, A.M.1
Snow, R.M.2
Frydenberg, M.3
-
19
-
-
18544411257
-
Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: Impact on Gleason score for non palpable lesions
-
Cornud F, Belin X, Piron D et al. Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for non palpable lesions. Urology 1997;49:709-15.
-
(1997)
Urology
, vol.49
, pp. 709-715
-
-
Cornud, F.1
Belin, X.2
Piron, D.3
-
20
-
-
0029006522
-
Correlation of transrectal ultrasound imaging and the results of systematic biopsy with pathological examination of radical prostatectomy specimens
-
Gohji K, Morisue K, Kizaki T, Fujii A. Correlation of transrectal ultrasound imaging and the results of systematic biopsy with pathological examination of radical prostatectomy specimens. Br J Urol 1995;75:758-65.
-
(1995)
Br J Urol
, vol.75
, pp. 758-765
-
-
Gohji, K.1
Morisue, K.2
Kizaki, T.3
Fujii, A.4
-
21
-
-
0028908683
-
Prostate cancer: Diagnosis with color Doppler sonography with histological correlation of each biopsy site
-
Newmann JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histological correlation of each biopsy site. Radiology 1995;195:86-90.
-
(1995)
Radiology
, vol.195
, pp. 86-90
-
-
Newmann, J.S.1
Bree, R.L.2
Rubin, J.M.3
-
22
-
-
0034004412
-
Using gray-scale and color and power Doppler sonography to detect prostatic cancer
-
Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000;174:623-7.
-
(2000)
AJR Am J Roentgenol
, vol.174
, pp. 623-627
-
-
Halpern, E.J.1
Strup, S.E.2
-
23
-
-
0037636338
-
Value of Power Doppler and 3D vascular sonography as a method for the diagnosis and staging of prostate cancer
-
Sauvain JL, Palascak P, Bourscheid D et al. Value of Power Doppler and 3D vascular sonography as a method for the diagnosis and staging of prostate cancer. Eur Urol 2003;44:21-31.
-
(2003)
Eur Urol
, vol.44
, pp. 21-31
-
-
Sauvain, J.L.1
Palascak, P.2
Bourscheid, D.3
-
24
-
-
0033802392
-
Endorectal color Doppler Sonography and endorectal MR, imaging feature of non palpable prostate cancer: Correlation with radical prostatectomy findings
-
Cornud F, Hamida K, Flam T et al. Endorectal color Doppler Sonography and endorectal MR, imaging feature of non palpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 2000;175:1161-8.
-
(2000)
AJR Am J Roentgenol
, vol.175
, pp. 1161-1168
-
-
Cornud, F.1
Hamida, K.2
Flam, T.3
-
25
-
-
0024393833
-
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
-
Hodge KK, Mcneal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-5.
-
(1989)
J Urol
, vol.142
, pp. 71-75
-
-
Hodge, K.K.1
Mcneal, J.E.2
Terris, M.K.3
Stamey, T.A.4
-
26
-
-
0027267407
-
Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long term follow up
-
Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long term follow up. J Urol 1993;150:135-41.
-
(1993)
J Urol
, vol.150
, pp. 135-141
-
-
Epstein, J.I.1
Carmichael, M.J.2
Pizov, G.3
Walsh, P.C.4
-
27
-
-
0032823983
-
Non palpable stage Tlc prostate cancer: Prediction of insignificant disease using free/total antigen levels and biopsy findings
-
Esptein JI, Chan W, Sokoll LJ, Walsch PC, Akingba G, Carter HB. Non palpable stage Tlc prostate cancer: prediction of insignificant disease using free/total antigen levels and biopsy findings. J Urol 1998;160:2407-11.
-
(1998)
J Urol
, vol.160
, pp. 2407-2411
-
-
Esptein, J.I.1
Chan, W.2
Sokoll, L.J.3
Walsch, P.C.4
Akingba, G.5
Carter, H.B.6
-
28
-
-
0028273083
-
Power Doppler US: A potential useful alternative to mean frequency based color Doppler US
-
Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potential useful alternative to mean frequency based color Doppler US. Radiology 1994;190:853-6.
-
(1994)
Radiology
, vol.190
, pp. 853-856
-
-
Rubin, J.M.1
Bude, R.O.2
Carson, P.L.3
Bree, R.L.4
Adler, R.S.5
-
29
-
-
0035283139
-
Characteristics of normal prostate vascular anatomy as displayed by power Doppler
-
Leventis AK, Shariat SF, Utsunomiya T, Slavim KT. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 2001;46:281-8.
-
(2001)
Prostate
, vol.46
, pp. 281-288
-
-
Leventis, A.K.1
Shariat, S.F.2
Utsunomiya, T.3
Slavim, K.T.4
-
30
-
-
2442715038
-
Prevalence of prostate cancer among men with a prostate specific antigen level < or =4,0ng per milliliter
-
Thompson IM, Pauler DK, Goodmann PJ et al. Prevalence of prostate cancer among men with a prostate specific antigen level < or =4,0ng per milliliter. N Engl J med 2004;350:2239-46.
-
(2004)
N Engl J Med
, vol.350
, pp. 2239-2246
-
-
Thompson, I.M.1
Pauler, D.K.2
Goodmann, P.J.3
-
31
-
-
0035667653
-
Contemporary update of prostate staging nomogramm (Partin tables) of the new millenium
-
Partin AW, Mangold LA, Lann DH, Walsch PC, Esptein JL, Pearson JD. Contemporary update of prostate staging nomogramm (Partin tables) of the new millenium. Urology 2001;58:843-8.
-
(2001)
Urology
, vol.58
, pp. 843-848
-
-
Partin, A.W.1
Mangold, L.A.2
Lann, D.H.3
Walsch, P.C.4
Esptein, J.L.5
Pearson, J.D.6
-
32
-
-
4444301437
-
Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy
-
Remzi M, Dobrovits M, Reissigl A et al. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy. Eur Urol 2004:46:451-6.
-
(2004)
Eur Urol
, vol.46
, pp. 451-456
-
-
Remzi, M.1
Dobrovits, M.2
Reissigl, A.3
-
33
-
-
0034042438
-
Transrectal power Doppler imaging in the detection of prostate cancer
-
Okihara K, Kojima M, Nakanouchi I, Okada K, Miki T. Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 2000;85:1053-7.
-
(2000)
BJU Int
, vol.85
, pp. 1053-1057
-
-
Okihara, K.1
Kojima, M.2
Nakanouchi, I.3
Okada, K.4
Miki, T.5
-
34
-
-
0028158669
-
Predictors of pathologic stage in prostatic carcinoma: The role of neovascularity
-
Brawer Mk, Deering Re, Brown M. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994;73:678-87.
-
(1994)
Cancer
, vol.73
, pp. 678-687
-
-
Brawer, Mk.1
Deering, Re.2
Brown, M.3
-
35
-
-
0027717345
-
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
-
Weidner N, Caroll Pr, Flax J, Folkmann J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 1993;143:401-9.
-
(1993)
Am J Pathol
, vol.143
, pp. 401-409
-
-
Weidner, N.1
Caroll, Pr.2
Flax, J.3
Folkmann, J.4
-
36
-
-
0036718369
-
Reactive stroma in human Prostate cancer. Induction of myofibroblast phenotype and extra matrix remodeling
-
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Rowley Dr. Reactive stroma in human Prostate cancer. Induction of myofibroblast phenotype and extra matrix remodeling. Clin Cancer Res 2002;8:2912-23.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2912-2923
-
-
Tuxhorn, J.A.1
Ayala, G.E.2
Smith, M.J.3
Smith, V.C.4
Rowley, Dr.5
-
37
-
-
0037815077
-
Correlation of minute (0.5mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimens: Role of prostate antigen density
-
Allan RW, Sanderson H, Esptein JI. Correlation of minute (0.5mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimens: role of prostate antigen density. J Urol 2003,170:370-2.
-
(2003)
J Urol
, vol.170
, pp. 370-372
-
-
Allan, R.W.1
Sanderson, H.2
Esptein, J.I.3
-
38
-
-
1642365689
-
The risk of finding focal cancer (less than 3mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
-
Zackrisson B, Aus G, Bergdahl S et al. The risk of finding focal cancer (less than 3mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 2004;171:1500-3.
-
(2004)
J Urol
, vol.171
, pp. 1500-1503
-
-
Zackrisson, B.1
Aus, G.2
Bergdahl, S.3
-
39
-
-
0035902795
-
Frequency of PSA-mRNA- bearing cells in the peripheral blood of patients after prostate biopsy
-
Hara N, Kasahara T, Kawasaki T et al. Frequency of PSA-mRNA- bearing cells in the peripheral blood of patients after prostate biopsy. Br J Cancer 2001;85:557-62.
-
(2001)
Br J Cancer
, vol.85
, pp. 557-562
-
-
Hara, N.1
Kasahara, T.2
Kawasaki, T.3
|